www.fdanews.com/articles/137673-neoprobe-files-response-to-citizen-petition
Neoprobe Files Response to Citizen Petition
June 16, 2011
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a formal response has been filed to a Citizen Petition submitted to the Food and Drug Administration on June 7, 2011 regarding the Company’s pending New Drug Application (NDA) for its lead radiopharmaceutical product, Lymphoseek.
The Street
The Street